BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26593444)

  • 1. The estrogenic effect of trigonelline and 3,3-diindolymethane on cell growth in non-malignant colonocytes.
    Yoo G; Allred CD
    Food Chem Toxicol; 2016 Jan; 87():23-30. PubMed ID: 26593444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorghum phenolics demonstrate estrogenic action and induce apoptosis in nonmalignant colonocytes.
    Yang L; Allred KF; Geera B; Allred CD; Awika JM
    Nutr Cancer; 2012 Apr; 64(3):419-27. PubMed ID: 22369068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trigonelline is a novel phytoestrogen in coffee beans.
    Allred KF; Yackley KM; Vanamala J; Allred CD
    J Nutr; 2009 Oct; 139(10):1833-8. PubMed ID: 19710155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced action of apigenin and naringenin combination on estrogen receptor activation in non-malignant colonocytes: implications on sorghum-derived phytoestrogens.
    Yang L; Allred KF; Dykes L; Allred CD; Awika JM
    Food Funct; 2015 Mar; 6(3):749-55. PubMed ID: 25553799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 mediates estradiol induced activation of apoptosis and DNA repair in non-malignant colonocytes.
    Weige CC; Allred KF; Armstrong CM; Allred CD
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):113-20. PubMed ID: 22100717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells.
    Sakamoto T; Horiguchi H; Oguma E; Kayama F
    J Nutr Biochem; 2010 Sep; 21(9):856-64. PubMed ID: 19800779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of in vitro growth and arrest in the G0/G1 phase of HCT8 line human colon cancer cells by kaempferide triglycoside from Dianthus caryophyllus.
    Martineti V; Tognarini I; Azzari C; Carbonell Sala S; Clematis F; Dolci M; Lanzotti V; Tonelli F; Brandi ML; Curir P
    Phytother Res; 2010 Sep; 24(9):1302-8. PubMed ID: 20104502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway.
    Li XJ; Park ES; Park MH; Kim SM
    Oncol Rep; 2013 Nov; 30(5):2419-26. PubMed ID: 24008339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon.
    Weige CC; Allred KF; Allred CD
    Cancer Res; 2009 Dec; 69(23):9118-24. PubMed ID: 19903848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC, a novel estrone-rhein hybrid compound, promotes proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells.
    Wang Y; Li LZ; Zhang YL; Sun WJ; Zhu YQ; Cui Y; Qi L
    Mol Cell Endocrinol; 2011 Sep; 344(1-2):59-68. PubMed ID: 21767602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity.
    Arlt A; Sebens S; Krebs S; Geismann C; Grossmann M; Kruse ML; Schreiber S; Schäfer H
    Oncogene; 2013 Oct; 32(40):4825-35. PubMed ID: 23108405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens.
    Boué SM; Wiese TE; Nehls S; Burow ME; Elliott S; Carter-Wientjes CH; Shih BY; McLachlan JA; Cleveland TE
    J Agric Food Chem; 2003 Apr; 51(8):2193-9. PubMed ID: 12670155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
    Kuiper GG; Lemmen JG; Carlsson B; Corton JC; Safe SH; van der Saag PT; van der Burg B; Gustafsson JA
    Endocrinology; 1998 Oct; 139(10):4252-63. PubMed ID: 9751507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells.
    Cho SD; Lei P; Abdelrahim M; Yoon K; Liu S; Guo J; Papineni S; Chintharlapalli S; Safe S
    Mol Carcinog; 2008 Apr; 47(4):252-63. PubMed ID: 17957723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and potentiation of interferon-gamma signaling by 3,3'-diindolylmethane in MCF-7 breast cancer cells.
    Riby JE; Xue L; Chatterji U; Bjeldanes EL; Firestone GL; Bjeldanes LF
    Mol Pharmacol; 2006 Feb; 69(2):430-9. PubMed ID: 16267208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.
    Rajoria S; Suriano R; George A; Shanmugam A; Schantz SP; Geliebter J; Tiwari RK
    PLoS One; 2011 Jan; 6(1):e15879. PubMed ID: 21267453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,3'-Diindolylmethane suppresses growth of human esophageal squamous cancer cells by G1 cell cycle arrest.
    Kim SJ; Lee JS; Kim SM
    Oncol Rep; 2012 May; 27(5):1669-73. PubMed ID: 22293900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells.
    Jin Y; Zou X; Feng X
    Anticancer Drugs; 2010 Oct; 21(9):814-22. PubMed ID: 20724916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.